Skip to main navigation Skip to search Skip to main content

Is intermediate radiation dose escalation with concurrent chemotherapy for stage III non-small-cell lung cancer beneficial? A multi-institutional propensity score matched analysis

  • George Rodrigues
  • , Cary Oberije
  • , Suresh Senan
  • , Kayoko Tsujino
  • , Terry Wiersma
  • , Marta Moreno-Jimenez
  • , Tae Hyun Kim
  • , Lawrence B. Marks
  • , Ramesh Rengan
  • , Luigi De Petris
  • , Sara Ramella
  • , Kim DeRuyck
  • , Núria Rodriguez De Dios
  • , Andrew Warner
  • , Jeffrey D. Bradley
  • , David A. Palma

    Research output: Contribution to journal › Article › peer-review

    17   Link opens in a new tab Scopus citations

    Fingerprint

    Dive into the research topics of 'Is intermediate radiation dose escalation with concurrent chemotherapy for stage III non-small-cell lung cancer beneficial? A multi-institutional propensity score matched analysis'. Together they form a unique fingerprint.
    Sort by

    Medicine and Dentistry

    Keyphrases